BioLineRx Ltd. (BLRX) shares are trading at higher $1.98 and the avg recommendation for the stock is Strong Buy.
To add more color to this target, the company’s high over the last year is $3.04 and the low is $1.06. Over the last 52 weeks, BLRX is down -24.14% while the S&P 500 is up 7.65%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, BLRX reported a profit of $0.4 million. BioLineRx Ltd. also saw revenues increase to $5.57 million. In addition, BLRX has free cash flow of -$12.3 million as of 06-2020. The company’s EBITDA came in at -$5.35 million which compares well with its peers.
Find out when BLRX reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. BLRX has a short ratio of 6.38 and outstanding shares of 19.98M.
BLRX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 26.7 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -2.33. BioLineRx Ltd. BLRX also noted assets of $52.99 million at the end of the last quarter. Investors should also keep an eye on sector updates as BLRX has historically followed its peers on positive news.
All told, BioLineRx Ltd. BLRX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, BLRX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
BioLineRx Ltd. BLRX is now commanding a market cap of 39.57M and a float of 18.08M. BLRX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of BLRX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in BLRX, either long or short, and we have not been compensated for this article.